ConnectOne Bancorp, Inc. Completes Merger With the First of Long Island Corporation

ConnectOne Bancorp, Inc. Completes Merger With the First of Long Island Corporation GlobeNewswire June 02, 2025 ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced the completion of its previously announced merger with The First of Long […]

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia GlobeNewswire June 02, 2025 – Robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms – – Generally well-tolerated with low rates of adverse events and discontinuation – – Brilaroxazine improved multiple neuroinflammatory markers

Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader GlobeNewswire June 02, 2025 Phase 1 healthy volunteer data of KT-621, a once-a-day STAT6 degrader, surpass Kymera's target product profile, significantly derisking program and further validating its oral, biologics-like profile >90% mean STAT6 degradation in

Rocky Shore Announces the Sale of its Hemlo-Area Claims

Rocky Shore Announces the Sale of its Hemlo-Area Claims GlobeNewswire June 02, 2025 TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (the “Company”) (CSE:RSG) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) with a subsidiary of Barrick Mining Corporation (“Barrick”) to sell its Hemlo-area mineral claims

Village Farms International Announces Closing of Transaction to Privatize its Fresh Produce Business

Village Farms International Announces Closing of Transaction to Privatize its Fresh Produce Business GlobeNewswire June 02, 2025 – Closing of transaction places Company in net cash position, poised for leadership in global cannabis industry – – Company plans to file proforma financial statements excluding discontinued operations within four business days – VANCOUVER, British Columbia, June

Nokia and Andorix partner to accelerate Private 5G and Edge Solutions in North American real estate market

Nokia and Andorix partner to accelerate Private 5G and Edge Solutions in North American real estate market Private 5G, Neutral Host Network and Edge Application OT solutions enabled by Nokia Digital Automation Cloud (DAC) to enable efficient building operations and improve tenant's satisfaction GlobeNewswire June 02, 2025 SAVANNAH, Ga. and TORONTO, June 02, 2025 (GLOBE

Denodo University Challenge Now Open: Data and AI for Real-World Impact

Denodo University Challenge Now Open: Data and AI for Real-World Impact Challenge Calls on All Students to Demonstrate Data Management Skills, with Free, Easy-to-Use Data Management and AI Tools, to Effect Social Change GlobeNewswire June 02, 2025 PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Denodo, a leader in data management, announced that the

Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer

Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer GlobeNewswire June 02, 2025 DALLAS, June 02, 2025 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced the appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS) GlobeNewswire June 02, 2025 ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi GlobeNewswire June 02, 2025 –Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi — REX-8756 is a potent and selective oral STAT6 inhibitor

Scroll to Top